Aardvark TherapeuticsAARD
13F holders, Q1 2025 (March 31)27holders
2famous investors
$7.50avg. 13F price*
At the end of Q1 2025, 27 institutions reported holding Aardvark Therapeutics Inc. (AARD) in their 13F filings. The largest holders were Decheng Capital LLC ($29.4M), Citadel Advisors ($9.4M) and Laurion Capital Management LP ($6.1M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Aardvark Therapeutics Inc.
- CUSIP
- 002942100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 27 | $65.1M |
| Exits | 0 | $0 |
Ownership 27 holders
| Decheng Capital LLC | 8.25% | New | 3,917,299 | $29.4M |
| Citadel Advisors | 0.01% | New | 1,274,084 | $9.4M |
| Laurion Capital Management LP | 0.48% | New | 808,243 | $6.1M |
| Cormorant Asset Management, LP | 0.46% | New | 800,189 | $6.0M |
| Braidwell LP | 0.20% | New | 500,000 | $3.8M |
| Montanova Capital, LLC | 0.10% | New | 312,500 | $2.3M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | New | 250,000 | $1.9M |
| Vanguard Group Inc. | 0.00% | New | 165,491 | $1.2M |
| Schonfeld Strategic Advisors LLC | 0.01% | New | 143,951 | $1.1M |
| Silverarc Capital Management, LLC | 0.19% | New | 119,496 | $897K |
| Cantor Fitzgerald, L. P. | 0.02% | New | 66,682 | $501K |
| Millennium Management | 0.00% | New | 65,640 | $493K |
| Geode Capital Management, LLC | 0.00% | New | 59,600 | $448K |
| Balyasny Asset Management L.P. | 0.00% | New | 35,435 | $266K |
| BNP Paribas Financial Markets | 0.00% | New | 34,690 | $261K |
| Goldman Sachs Group Inc. | 0.00% | New | 20,311 | $153K |
| BlackRock, Inc. | 0.00% | New | 18,776 | $141K |
| Two Sigma Investments, LP | 0.00% | New | 15,424 | $116K |
| UBS Group AG | 0.00% | New | 14,705 | $110K |
| Squarepoint Ops LLC | 0.00% | New | 14,186 | $107K |
| Northern Trust Corp. | 0.00% | New | 14,001 | $105K |
| Point72 (DIFC) Ltd | 0.01% | New | 12,797 | $96K |
| Walleye Capital LLC | 0.00% | New | 11,730 | $88K |
| Bank of America Corp. | 0.00% | New | 4,620 | $35K |
| JPMorgan Chase & Co. | 0.00% | New | 3,100 | $23K |
| Morgan Stanley | 0.00% | New | 2,218 | $17K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.00% | New | 1,284 | $10K |
"% of holder's portfolio" is AARD's weight in each manager's 13F, not the share of Aardvark Therapeutics Inc. the manager owns.